Publications by authors named "Tracy Curley"

Claim this Profile
A
A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.
E David Crawford, Marc B Garnick, Robert H Eckel, Martin M Miner, Stephen J Freedland, Tracy Curley

Urol Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
Jimmy L Zhao, Emmanuel S Antonarakis, Heather H Cheng, Daniel J George, Rahul Aggarwal, Tracy Curley

Br J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
E David Crawford, Marc B Garnick, Robert H Eckel, Martin M Miner, Stephen J Freedland, Tracy Curley

Urol Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Susan F Slovin, Karen Knudsen, Susan Halabi, Renee de Leeuw, Ayesha Shafi, Tracy Curley

J Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
Laura Graham, Kalyan Banda, Alba Torres, Brett S Carver, Yu Chen, Tracy Curley

Invest New Drugs· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nursing management of patients with castration-resistant prostate cancer undergoing radium-223 dichloride treatment.
Anthony Delacruz, Gabrielle Arauz, Tracy Curley, Amabella Lindo, Trine Jensen

Clin J Oncol Nurs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.
Gopa Iyer, Michael J Morris, Dana Rathkopf, Susan F Slovin, Macaulay Steers, Tracy Curley

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
Michael J Morris, Daisy Huang, William K Kelly, Susan F Slovin, Ryan D Stephenson, Tracy Curley

Eur Urol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
Michael J Morris, Neeta Pandit-Taskar, Jorge Carrasquillo, Chaitanya R Divgi, Susan Slovin, Tracy Curley

J Clin Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
Dana Rathkopf, Michael A Carducci, Michael J Morris, Susan F Slovin, Mario A Eisenberger, Tracy Curley

J Clin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
David B Solit, S Percy Ivy, Catherine Kopil, Rachel Sikorski, Michael J Morris, Tracy Curley

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid androgen cycling as treatment for patients with prostate cancer.
David Feltquate, Luke Nordquist, Caitlin Eicher, Michael Morris, Oren Smaletz, Tracy Curley

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid.
Lee M Krug, Tracy Curley, Lawrence Schwartz, Stacie Richardson, Paul Marks

Clin Lung Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.
Michael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, Maria Batraki, Nyasha Warren, Tracy Curley

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.
William Kevin Kelly, Owen A O'Connor, Lee M Krug, Judy H Chiao, Mark Heaney, Tracy Curley

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
Matthew D Galsky, Eric J Small, William K Oh, Isan Chen, David C Smith, Tracy Curley

J Clin Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Michael J Morris, Oren Smaletz, David Solit, W Kevin Kelly, Susan Slovin, Tracy Curley

Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
David B Solit, Michael Morris, Susan Slovin, Tracy Curley, Lawrence Schwartz

Cancer· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
Wm Kevin Kelly, Victoria M Richon, Owen O'Connor, Tracy Curley, Barbara MacGregor-Curtelli

Clin Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.
David Andrew Verbel, W Kevin Kelly, Oren Smaletz, Kevin Regan, Tracy Curley

Urology· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis